Literature DB >> 30576563

Aberrant Frontostriatal Connectivity in Negative Symptoms of Schizophrenia.

Dinesh K Shukla1, Joshua John Chiappelli1, Hemalatha Sampath1, Peter Kochunov1, Stephanie M Hare1, Krista Wisner1, Laura M Rowland1, L Elliot Hong1.   

Abstract

Negative symptoms represent a distinct component of psychopathology in schizophrenia (SCZ) and are a stable construct over time. Although impaired frontostriatal connectivity has been frequently described in SCZ, its link with negative symptoms has not been carefully studied. We tested the hypothesis that frontostriatal connectivity at rest may be associated with the severity of negative symptoms in SCZ. Resting state functional connectivity (rsFC) data from 95 mostly medicated patients with SCZ and 139 healthy controls (HCs) were acquired. Negative symptoms were assessed using the Brief Negative Symptom Scale. The study analyzed voxel-wise rsFC between 9 frontal "seed regions" and the entire striatum, with the intention to reduce potential biases introduced by predefining any single frontal or striatal region. SCZ showed significantly reduced rsFC between the striatum and the right medial and lateral orbitofrontal cortex (OFC), lateral prefrontal cortex, and rostral anterior cingulate cortex compared with HCs. Further, rsFC between the striatum and the right medial OFC was significantly associated with negative symptom severity. The involved striatal regions were primarily at the ventral putamen. Our results support reduced frontostriatal functional connectivity in SCZ and implicate striatal connectivity with the right medial OFC in negative symptoms. This task-independent resting functional magnetic resonance imaging study showed that medial OFC-striatum functional connectivity is reduced in SCZ and associated with severity of negative symptoms. This finding supports a significant association between frontostriatal connectivity and negative symptoms and thus may provide a potential circuitry-level biomarker to study the neurobiological mechanisms of negative symptoms.
© The Author(s) 2018. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  functional connectivity; negative symptoms; schizophrenia

Mesh:

Year:  2019        PMID: 30576563      PMCID: PMC6737477          DOI: 10.1093/schbul/sby165

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  63 in total

Review 1.  The functions of the orbitofrontal cortex.

Authors:  Edmund T Rolls
Journal:  Brain Cogn       Date:  2004-06       Impact factor: 2.310

Review 2.  Defining and measuring negative symptoms of schizophrenia in clinical trials.

Authors:  Stephen R Marder; Brian Kirkpatrick
Journal:  Eur Neuropsychopharmacol       Date:  2013-11-11       Impact factor: 4.600

Review 3.  The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans.

Authors:  D Ongür; J L Price
Journal:  Cereb Cortex       Date:  2000-03       Impact factor: 5.357

4.  Deficits in positive reinforcement learning and uncertainty-driven exploration are associated with distinct aspects of negative symptoms in schizophrenia.

Authors:  Gregory P Strauss; Michael J Frank; James A Waltz; Zuzana Kasanova; Ellen S Herbener; James M Gold
Journal:  Biol Psychiatry       Date:  2010-12-17       Impact factor: 13.382

Review 5.  Do we still believe in the dopamine hypothesis? New data bring new evidence.

Authors:  Anissa Abi-Dargham
Journal:  Int J Neuropsychopharmacol       Date:  2004-03       Impact factor: 5.176

6.  Frontal-striatal cognitive deficits in patients with chronic schizophrenia.

Authors:  C Pantelis; T R Barnes; H E Nelson; S Tanner; L Weatherley; A M Owen; T W Robbins
Journal:  Brain       Date:  1997-10       Impact factor: 13.501

7.  Frontostriatal connectivity and its role in cognitive control in parent-child dyads with ADHD.

Authors:  B J Casey; Jeffery N Epstein; Jason Buhle; Conor Liston; Matthew C Davidson; Simon T Tonev; Julie Spicer; Sumit Niogi; Alexander J Millner; Allan Reiss; Amy Garrett; Stephen P Hinshaw; Laurence L Greenhill; Keith M Shafritz; Alan Vitolo; Lisa A Kotler; Matthew A Jarrett; Gary Glover
Journal:  Am J Psychiatry       Date:  2007-11       Impact factor: 18.112

8.  Dopaminergic drug effects on physiological connectivity in a human cortico-striato-thalamic system.

Authors:  G D Honey; J Suckling; F Zelaya; C Long; C Routledge; S Jackson; V Ng; P C Fletcher; S C R Williams; J Brown; E T Bullmore
Journal:  Brain       Date:  2003-06-04       Impact factor: 13.501

9.  Prefrontal and Striatal Glutamate Differently Relate to Striatal Dopamine: Potential Regulatory Mechanisms of Striatal Presynaptic Dopamine Function?

Authors:  Tobias Gleich; Lorenz Deserno; Robert Christian Lorenz; Rebecca Boehme; Anne Pankow; Ralph Buchert; Simone Kühn; Andreas Heinz; Florian Schlagenhauf; Jürgen Gallinat
Journal:  J Neurosci       Date:  2015-07-01       Impact factor: 6.167

10.  Voxel-based gray and white matter morphometry correlates of hallucinations in schizophrenia: The superior temporal gyrus does not stand alone.

Authors:  Marie-José van Tol; Lisette van der Meer; Richard Bruggeman; Gemma Modinos; Henderikus Knegtering; André Aleman
Journal:  Neuroimage Clin       Date:  2013-12-29       Impact factor: 4.881

View more
  10 in total

Review 1.  Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment.

Authors:  Masataka Wada; Yoshihiro Noda; Yusuke Iwata; Sakiko Tsugawa; Kazunari Yoshida; Hideaki Tani; Yoji Hirano; Shinsuke Koike; Daiki Sasabayashi; Haruyuki Katayama; Eric Plitman; Kazutaka Ohi; Fumihiko Ueno; Fernando Caravaggio; Teruki Koizumi; Philip Gerretsen; Takefumi Suzuki; Hiroyuki Uchida; Daniel J Müller; Masaru Mimura; Gary Remington; Anthony A Grace; Ariel Graff-Guerrero; Shinichiro Nakajima
Journal:  Mol Psychiatry       Date:  2022-04-20       Impact factor: 15.992

2.  Altered Spontaneous Brain Activity Patterns of Meibomian Gland Dysfunction in Severely Obese Population Measured Using the Fractional Amplitude of Low-Frequency Fluctuations.

Authors:  Yu-Ling Xu; Xiao-Yu Wang; Jun Chen; Min Kang; Yi-Xin Wang; Li-Juan Zhang; Hui-Ye Shu; Xu-Lin Liao; Jie Zou; Hong Wei; Qian Ling; Yi Shao
Journal:  Front Psychiatry       Date:  2022-05-11       Impact factor: 5.435

3.  Brain activity and connectivity differences in reward value discrimination during effort computation in schizophrenia.

Authors:  Clara Pretus; Daniel Bergé; Xavier Guell; Victor Pérez; Óscar Vilarroya
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-06-03       Impact factor: 5.270

4.  Impact of Positive Emotion Regulation Training on Negative Symptoms and Social Functioning in Schizophrenia: A Field Test.

Authors:  Jérôme Favrod; Alexandra Nguyen; Anne-Marie Tronche; Olivier Blanc; Julien Dubreucq; Isabelle Chereau-Boudet; Delphine Capdevielle; Pierre Michel Llorca
Journal:  Front Psychiatry       Date:  2019-07-26       Impact factor: 4.157

5.  Intermittent theta burst stimulation for negative symptoms of schizophrenia-A double-blind, sham-controlled pilot study.

Authors:  Marine Mondino; Jérôme Brunelin; Rémy Bation; Charline Magnin; Emmanuel Poulet
Journal:  NPJ Schizophr       Date:  2021-02-12

6.  Abnormal functional connectivity of the striatum in first-episode drug-naive early-onset Schizophrenia.

Authors:  Yan Zhang; Yue Peng; Yichen Song; Youqi Zhou; Sen Zhang; Ge Yang; Yongfeng Yang; Wenqiang Li; Weihua Yue; Luxian Lv; Dai Zhang
Journal:  Brain Behav       Date:  2022-04-05       Impact factor: 3.405

7.  Aberrant Functional Connectivity of the Orbitofrontal Cortex Is Associated With Excited Symptoms in First-Episode Drug-Naïve Patients With Schizophrenia.

Authors:  Congxin Chen; Jingjing Yao; Yiding Lv; Xiaoxin Zhao; Xinyue Zhang; Jiaxi Lei; Yuan Li; Yuxiu Sui
Journal:  Front Psychiatry       Date:  2022-07-28       Impact factor: 5.435

8.  Meta-analysis of structural and functional brain abnormalities in schizophrenia with persistent negative symptoms using activation likelihood estimation.

Authors:  Tingting Zhu; Zixu Wang; Chao Zhou; Xinyu Fang; Chengbing Huang; Chunming Xie; Honglin Ge; Zheng Yan; Xiangrong Zhang; Jiu Chen
Journal:  Front Psychiatry       Date:  2022-09-27       Impact factor: 5.435

Review 9.  Neuroimaging Heterogeneity in Psychosis: Neurobiological Underpinnings and Opportunities for Prognostic and Therapeutic Innovation.

Authors:  Aristotle N Voineskos; Grace R Jacobs; Stephanie H Ameis
Journal:  Biol Psychiatry       Date:  2019-09-17       Impact factor: 13.382

10.  Genetic Contribution of Synapse-Associated Protein 97 to Orbitofrontal-Striatal-Thalamic Circuitry Connectivity Changes in First-Episode Schizophrenia.

Authors:  Xusan Xu; Shucun Luo; Xia Wen; Xiaoxia Wang; Jingwen Yin; Xudong Luo; Bin He; Chunmei Liang; Susu Xiong; Dongjian Zhu; Jiawu Fu; Dong Lv; Zhun Dai; Juda Lin; You Li; Zhixiong Lin; Wubiao Chen; Zebin Luo; Yajun Wang; Guoda Ma
Journal:  Front Psychiatry       Date:  2021-07-19       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.